{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:12:54Z","timestamp":1784628774032,"version":"3.55.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T00:00:00Z","timestamp":1705968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate the proportion and distribution of contrast enhancement (CE) of musculoskeletal structures with MRI of the thorax\/abdomen\/pelvis in giant cell arteritis (GCA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>CE at 34 musculoskeletal sites was rated with a four-point ordinal scale. Patients were divided into groups with or without glucocorticoid (GC) treatment and with or without symptoms of polymyalgia rheumatica (PMR). Two composite scores were created: an MRI score, including seven sites, and a limited MRI score, including four sites.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Retrospectively, 90 consecutive patients with GCA were included. The population included 54 and 36 patients with and without PMR symptoms, respectively, and 45 (50%) patients were receiving GCs at the time of MRI. CE was found in 90.7% of lumbar spines, 87.5% of the pelvis, 82.2% of shoulder girdles and in 95.6% at any site in patients without GCs. The proportion of patients without and with GCs with at least moderate enhancement was, respectively, 91.1% and 75.6% at \u22651\u20133 sites, 75.6% and 51.1% at \u22654\u20136 sites, and 64.4% and 28.9% at \u22657\u20139 sites. The mean difference between the proportion of pathological CE in patients with and without GCs was 27.4% for synovial sites and 18.3% for periarticular\/musculotendinous sites. Both composite scores captured substantial differences between groups, and correlation was very strong between scores.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>MRI shows CE of musculoskeletal structures typical of PMR in most patients with GCA, supporting the concept of \u2018GCA-PMR spectrum disease\u2019. Changes are more frequent at periarticular\/musculotendinous sites and in the presence of PMR symptoms. A clear response to GCs is evident, less so for periarticular\/musculotendinous sites.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae043","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T14:05:13Z","timestamp":1706105113000},"page":"321-331","source":"Crossref","is-referenced-by-count":13,"title":["Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumatica"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2002-9851","authenticated-orcid":false,"given":"Pascal","family":"Seitz","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, University Hospital Bern, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Cullmann","sequence":"additional","affiliation":[{"name":"Campusradiologie, Lindenhofgruppe , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Bucher","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, University Hospital Bern, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"B\u00fctikofer","sequence":"additional","affiliation":[{"name":"CTU Bern, Department of Clinical Research, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8098-6567","authenticated-orcid":false,"given":"Stephan","family":"Reichenbach","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, University Hospital Bern, University of Bern , Bern,","place":["Switzerland"]},{"name":"Institute for Social and Preventive Medicine, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"L\u00f6tscher","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, University Hospital Bern, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7049-2926","authenticated-orcid":false,"given":"Jennifer","family":"Amsler","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, University Hospital Bern, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7358-2051","authenticated-orcid":false,"given":"Lisa","family":"Christ","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, University Hospital Bern, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald M","family":"Bonel","sequence":"additional","affiliation":[{"name":"Campusradiologie, Lindenhofgruppe , Bern,","place":["Switzerland"]},{"name":"Department of Diagnostic, Interventional and Paediatric Radiology, Inselspital, University Hospital Bern, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8859-9964","authenticated-orcid":false,"given":"Peter M","family":"Villiger","sequence":"additional","affiliation":[{"name":"Rheumatology and Immunology, Medical Center Monbijou , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5051-1445","authenticated-orcid":false,"given":"Luca","family":"Seitz","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Inselspital, University Hospital Bern, University of Bern , Bern,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,23]]},"reference":[{"key":"2025010608404951100_keae043-B1","first-page":"506","article-title":"The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease","volume":"56","author":"Dejaco","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2025010608404951100_keae043-B2","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"key":"2025010608404951100_keae043-B3","doi-asserted-by":"crossref","first-page":"1759720X221149963","DOI":"10.1177\/1759720X221149963","article-title":"Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica\u2014a prospective cohort study","volume":"15","author":"Burg","year":"2023","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"2025010608404951100_keae043-B4","doi-asserted-by":"crossref","first-page":"152017","DOI":"10.1016\/j.semarthrit.2022.152017","article-title":"Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data","volume":"55","author":"Hemmig","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2025010608404951100_keae043-B5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41584-023-00976-8","article-title":"Disease stratification in GCA and PMR: state of the art and future perspectives","volume":"19","author":"Tomelleri","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2025010608404951100_keae043-B6","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/acr2.11163","article-title":"The utility of 18F-FDG PET\/CT in patients with clinical suspicion of polymyalgia rheumatica and giant cell arteritis: a prospective, observational, and cross-sectional study","volume":"2","author":"Emamifar","year":"2020","journal-title":"ACR Open Rheumatol"},{"key":"2025010608404951100_keae043-B7","doi-asserted-by":"crossref","first-page":"e000100","DOI":"10.1136\/rmdopen-2015-000100","article-title":"Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review","volume":"1","author":"Mackie","year":"2015","journal-title":"RMD Open"},{"key":"2025010608404951100_keae043-B8","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1136\/annrheumdis-2015-207395","article-title":"Whole-body MRI of patients with polymyalgia rheumatica identifies a distinct subset with complete patient-reported response to glucocorticoids","volume":"74","author":"Mackie","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2025010608404951100_keae043-B9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3109\/14397595.2015.1008725","article-title":"MRI findings of the shoulder and hip joint in patients with polymyalgia rheumatica","volume":"25","author":"Ochi","year":"2015","journal-title":"Mod Rheumatol"},{"key":"2025010608404951100_keae043-B10","first-page":"86","article-title":"Use of contrast-enhanced magnetic resonance imaging of the pelvis to describe changes at different anatomic sites which are potentially specific for polymyalgia rheumatica","volume":"36(Suppl 114)","author":"Fruth","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2025010608404951100_keae043-B11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/rheumatology\/kex411","article-title":"Fusion of positron emission tomography\/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica","volume":"57","author":"Owen","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2025010608404951100_keae043-B12","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3899\/jrheum.190367","article-title":"Musculotendinous inflammation: the defining pathology of polymyalgia rheumatica?","volume":"46","author":"Owen","year":"2019","journal-title":"J Rheumatol"},{"key":"2025010608404951100_keae043-B13","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3899\/jrheum.180958","article-title":"Localized myofascial inflammation revealed by magnetic resonance imaging in recent-onset polymyalgia rheumatica and effect of tocilizumab therapy","volume":"46","author":"Laporte","year":"2019","journal-title":"J Rheumatol"},{"key":"2025010608404951100_keae043-B14","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/ard.2007.084723","article-title":"Cervical interspinous bursitis in active polymyalgia rheumatica","volume":"67","author":"Salvarani","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2025010608404951100_keae043-B15","first-page":"526","article-title":"Lumbar interspinous bursitis in active polymyalgia rheumatica","volume":"31","author":"Salvarani","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"2025010608404951100_keae043-B16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1186\/s13075-014-0492-2","article-title":"Interspinous bursitis is common in polymyalgia rheumatica, but is not associated with spinal pain","volume":"16","author":"Camellino","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2025010608404951100_keae043-B17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2967\/jnumed.122.265016","article-title":"Role of 18F-FDG PET\/CT in large vessel vasculitis and polymyalgia rheumatica","volume":"64","author":"Slart","year":"2023","journal-title":"J Nucl Med"},{"key":"2025010608404951100_keae043-B18","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/rheumatology\/kex376","article-title":"Use of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of polymyalgia rheumatica-a prospective study of 99 patients","volume":"57","author":"Henckaerts","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2025010608404951100_keae043-B19","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/rheumatology\/kew202","article-title":"Utility of 18F-fluoro-dexoxyglucose positron emission tomography for the diagnosis of polymyalgia rheumatica: a controlled study","volume":"55","author":"Sondag","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2025010608404951100_keae043-B20","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00259-020-04731-z","article-title":"Abnormalities at three musculoskeletal sites on whole-body positron emission tomography\/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity","volume":"47","author":"Owen","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025010608404951100_keae043-B21","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s00259-018-3973-8","article-title":"FDG-PET\/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC","volume":"45","author":"Slart","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025010608404951100_keae043-B22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.55563\/clinexprheumatol\/4r78yg","article-title":"Clinical and FDG-PET\/CT correlates in patients with polymyalgia rheumatica","volume":"40","author":"Camellino","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2025010608404951100_keae043-B23","article-title":"EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update","author":"Dejaco","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025010608404951100_keae043-B24","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1148\/radiol.14140056","article-title":"Giant cell arteritis: diagnostic accuracy of MR imaging of superficial cranial arteries in initial diagnosis-results from a multicenter trial","volume":"273","author":"Klink","year":"2014","journal-title":"Radiology"},{"key":"2025010608404951100_keae043-B25","article-title":"Diffusion-weighted magnetic resonance imaging for the diagnosis of giant cell arteritis\u2014a comparison with T1-weighted black-blood imaging","author":"Seitz","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2025010608404951100_keae043-B26","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/rheumatology\/key015","article-title":"Magnetic resonance angiography in giant cell arteritis: results of a randomized controlled trial of tocilizumab in giant cell arteritis","volume":"57","author":"Reichenbach","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2025010608404951100_keae043-B27","first-page":"w14397","article-title":"Diagnostic value of contrast-enhanced magnetic resonance angiography in large-vessel vasculitis","volume":"147","author":"Adler","year":"2017","journal-title":"Swiss Med Wkly"},{"key":"2025010608404951100_keae043-B28","doi-asserted-by":"crossref","first-page":"731.e11","DOI":"10.1016\/j.crad.2019.04.012","article-title":"Three-dimensional fat-saturated T1-weighted Cartesian volumetric interpolated breath-hold examination (VIBE) for the diagnosis of aortitis in patients with suspected large vessel vasculitis: a comparative study with 18F-FDG PET applying fully integrated PET\/MRI","volume":"74","author":"Einspieler","year":"2019","journal-title":"Clin Radiol"},{"key":"2025010608404951100_keae043-B29","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s00330-016-4525-x","article-title":"3D-black-blood 3T-MRI for the diagnosis of thoracic large vessel vasculitis: a feasibility study","volume":"27","author":"Treitl","year":"2017","journal-title":"Eur Radiol"},{"key":"2025010608404951100_keae043-B30","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/annrheumdis-2018-213102","article-title":"Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis","volume":"77","author":"Quinn","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2025010608404951100_keae043-B31","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/rheumatology\/keab483","article-title":"Comparison and validation of FDG-PET\/CT scores for polymyalgia rheumatica","volume":"61","author":"van der Geest","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025010608404951100_keae043-B32","doi-asserted-by":"crossref","first-page":"1026944","DOI":"10.3389\/fmed.2022.1026944","article-title":"Diagnostic accuracy and validation of 18F-fluorodeoxyglucose positron emission tomography scores in a large cohort of patients with polymyalgia rheumatica","volume":"9","author":"Moreel","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025010608404951100_keae043-B33","doi-asserted-by":"crossref","first-page":"646974","DOI":"10.3389\/fmed.2021.646974","article-title":"Decision tree with only two musculoskeletal sites to diagnose polymyalgia rheumatica using [18F]FDG PET-CT","volume":"8","author":"Flaus","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2025010608404951100_keae043-B34","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1007\/s00259-021-05362-8","article-title":"Diagnostic value of [18F]FDG-PET\/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis","volume":"48","author":"van der Geest","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2025010608404951100_keae043-B35","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1093\/rheumatology\/keab484","article-title":"Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis","volume":"60","author":"Seitz","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2025010608404951100_keae043-B36","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1093\/rheumatology\/kead028","article-title":"Ultrasonography in the assessment of disease activity in cranial and large-vessel giant cell arteritis: a prospective follow-up study","volume":"62","author":"Nielsen","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"2025010608404951100_keae043-B37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10334-005-0119-3","article-title":"Integrated head-thoracic vascular MRI at 3 T: assessment of cranial, cervical and thoracic involvement of giant cell arteritis","volume":"18","author":"Bley","year":"2005","journal-title":"MAGMA"},{"key":"2025010608404951100_keae043-B38","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2016"},{"key":"2025010608404951100_keae043-B39","volume-title":"Stata statistical software: release 17","author":"StataCorp","year":"2021"},{"key":"2025010608404951100_keae043-B40","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/rheumatology\/keaa014","article-title":"Diagnostic capability of contrast-enhanced pelvic girdle magnetic resonance imaging in polymyalgia rheumatica","volume":"59","author":"Fruth","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2025010608404951100_keae043-B41","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/ard-2022-223367","article-title":"The provisional OMERACT ultrasonography score for giant cell arteritis","volume":"82","author":"Dejaco","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2025010608404951100_keae043-B42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.semarthrit.2018.05.002","article-title":"Arterial lesions in giant cell arteritis: a longitudinal study","volume":"48","author":"Kermani","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2025010608404951100_keae043-B43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-127-1-199707010-00005","article-title":"Proximal bursitis in active polymyalgia rheumatica","volume":"127","author":"Salvarani","year":"1997","journal-title":"Ann Intern Med"},{"key":"2025010608404951100_keae043-B44","first-page":"208","article-title":"Magnetic Resonance Imaging in degenerative disease of the lumbar spine: fat Saturation technique and contrast medium","volume":"89","author":"D'Aprile","year":"2018","journal-title":"Acta Biomed"},{"key":"2025010608404951100_keae043-B45","doi-asserted-by":"crossref","first-page":"e3818","DOI":"10.1097\/MD.0000000000003818","article-title":"Giant-cell arteritis without cranial manifestations: working diagnosis of a distinct disease pattern","volume":"95","author":"de Boysson","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2025010608404951100_keae043-B46","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.ophtha.2016.05.008","article-title":"Evaluating the incidence of arteritic ischemic optic neuropathy and other causes of vision loss from giant cell arteritis","volume":"123","author":"Chen","year":"2016","journal-title":"Ophthalmology"},{"key":"2025010608404951100_keae043-B47","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3899\/jrheum.140188","article-title":"Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort","volume":"42","author":"Singh","year":"2015","journal-title":"J Rheumatol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae043\/56725361\/keae043.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/1\/321\/56725361\/keae043.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/1\/321\/56725361\/keae043.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T08:42:10Z","timestamp":1736152930000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/1\/321\/7587525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,23]]},"published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae043","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,1,23]]}}}